Dengvaxia controversy

The Dengvaxia controversy (Tagalog pronunciation: [dɛŋˈvakʃa]) was a health scare in the Philippines caused when the dengue fever vaccine Dengvaxia was found to increase the risk of disease severity for some people who had received it. A vaccination program had been run by the Philippine Department of Health (DOH) who had administered Sanofi Pasteur's Dengvaxia to schoolchildren.

Dengvaxia controversy

The Dengvaxia controversy (Tagalog pronunciation: [dɛŋˈvakʃa]) was a health scare in the Philippines caused when the dengue fever vaccine Dengvaxia was found to increase the risk of disease severity for some people who had received it. A vaccination program had been run by the Philippine Department of Health (DOH) who had administered Sanofi Pasteur's Dengvaxia to schoolchildren.